Why the consumer-driven world of healthcare still has its limits
Stop thinking consumers will pay for your app and start thinking about how it goes viral.
Your biggest fear about corporate investors may also be the biggest myth
Will a corporate VC close doors for you - or will they open up?
presented by
The 3 Best Options to Buy Telemedicine Carts for Neurology Care
Neurologists and health care practitioners must evolve with the world. Telemedicine carts assist in this evolution by serving as an intermediary between patients and doctors.
Take the MedCity News survey on corporate venture capital in digital health
There isn't as much insight and understanding of how these investors operate
Corporate ventures in life science are important, but generate mixed feelings
The shift in the stage of investment and where the perceived opportunities in biotech are have had a significant impact.
Read the MedCity News survey on corporate venture capital in healthcare
It's time to know more about corporate venture capital because, unlike traditional venture or angel groups, there's much less insight on corporate VCs and their practices.
A growing problem for healthcare startups seeking investment: (Almost) no one wants to lead
OK, it's a cheap shot to call them sheep. But there are too many followers among healthcare investors.
presented by
Improving Medical Billing to Cut Payment Bottlenecks
Yusuf Qasim, President of Payments Optimization at Zelis, discussed how the company is transforming healthcare payments from a fragmented, patchwork system into a modern, digital infrastructure.
Is the athenahealth accelerator term sheet disruptive or just awful?
Not everyone is a fan of this kind of disruption, thank you. But is the tradeoff worth it?
Medtech venture capital: Opportunistic vs. commitment styles of investment
Venture capitalists have been criticized of late for their opportunistic investing choices in medical devices – moving away from early stage investment and into safer, later-stage deals that herald larger returns. Early stage investment, dubbed commitment investing, requires that they accept a longer wait to exit. This is all but dying out in medical device venture capital – making it harder […]
From corporate venture and beyond: How healthcare startups find fund-raising success
Read this in-the-trenches view of fund-raising for life science companies. How has the landscape changed? And how can you better protect yourself as you start talking about your proprietary ideas to grant committee and big corporations? Find out who an entrepreneur's biggest ally is when they are doing healthcare fund-raising.
Friday is the deadline for you to shape how healthcare looks at corporate venture capital
We're reaching the finish line on MedCity News' survey on investing and corporate venture capital. Our deadline is Friday, so please take the survey and share your thoughts on the life science corporate VCs you know and have dealt with, as well as what your thoughts are on the modern environment for fund-raising in the life sciences.
presented by
6 Aesthetic Certification Programs That Include Both Theory and Practical Training
Explore top-tier aesthetic certification programs that blend theory with hands-on training — perfect for health care pros ready to elevate their practice
Which are the best life science corporate VCs? Take MedCity News’ survey
We need your help in getting better information on life science corporate venture capital funds. Will you share your thoughts on corporate VCs as well as the state of life science investing in general?
Google Ventures GP highlights complexities of using digital health to help disadvantaged patients
Given Google Ventures’ profile in healthcare investment, the companies it chooses to back make folks sit up and take notice. In a rare talk, Google Ventures General Partner Dr. Krishna Yeshwant shared some of the things that inform its investment choices and others what constrain them. MobiHealthNews highlighted the talk at the Hx Refactored conference in […]
Emerging sources of early-stage life science funding embrace the role of ‘venture catalysts’
It was nice to hear one healthcare executive and investor after another respond to the question, “what are your key priorities when evaluating a deal?” with the answer, “really compelling science.” I’ve often heard VCs and angel investors cite the importance of large addressable markets and talented executive teams as key considerations to a deal, […]
Sigh. Healthcare corporate venture capital investments hit five-quarter low in Q3
Corporate venture capital investments in healthcare hit a five-quarter low in Q3, down in both deals and funding, according to a new report out from CB Insights. Compared to the quarter before, deals and funding decreased by 41 percent and 27 percent respectively. The tried-and-true players fared well: California, Massachusetts and Minnesota grabbed the CVC […]
Here’s a look at healthcare’s top 10 corporate investors and acquirers
These days, having a strategic investor or partner has become almost a matter of survival for healthcare startups. Corporate investing and partnering has really taken off over the last few years as pharma and medical device companies have opened their doors and wallets to find innovation outside of their four walls. A new analysis from […]